These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 21109982)

  • 1. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp.
    He Q; Zhang G; Hou D; Leng A; Xu M; Peng J; Liu T
    Oncol Rep; 2011 Jan; 25(1):237-43. PubMed ID: 21109982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorcin a Potential Molecular Target for Cancer Therapy.
    Shabnam B; Padmavathi G; Banik K; Girisa S; Monisha J; Sethi G; Fan L; Wang L; Mao X; Kunnumakkara AB
    Transl Oncol; 2018 Dec; 11(6):1379-1389. PubMed ID: 30216763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells.
    Li WB; Li Y; Yu C; He YM
    Evid Based Complement Alternat Med; 2015; 2015():390812. PubMed ID: 25705237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways.
    Tito C; Genovese I; Giamogante F; Benedetti A; Miglietta S; Barazzuol L; Cristiano L; Iaiza A; Carolini S; De Angelis L; Masciarelli S; Nottola SA; Familiari G; Petrozza V; Lauriola M; Tamagnone L; Ilari A; Calì T; Valdivia HH; Valdivia CR; Colotti G; Fazi F
    Cell Mol Life Sci; 2023 Jul; 80(8):202. PubMed ID: 37442828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance and Prognostic Value of Human Soluble Resistance-Related Calcium-Binding Protein: A Pan-Cancer Analysis.
    Zhang J; Chen J; Shan B; Lin L; Dong J; Sun Q; Zhou Q; Han X
    Front Med (Lausanne); 2021; 8():752619. PubMed ID: 34869449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Zhang J; Guan W; Xu X; Wang F; Li X; Xu G
    Oncogene; 2021 Jul; 40(30):4906-4918. PubMed ID: 34163033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.
    Genovese I; Carinci M; Modesti L; Aguiari G; Pinton P; Giorgi C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flightless-1 inhibits ER stress-induced apoptosis in colorectal cancer cells by regulating Ca
    Choi SS; Lee SK; Kim JK; Park HK; Lee E; Jang J; Lee YH; Khim KW; Hyun JM; Eom HJ; Lee S; Kang BH; Chae YC; Myung K; Myung SJ; Park CY; Choi JH
    Exp Mol Med; 2020 Jun; 52(6):940-950. PubMed ID: 32504039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.
    Battista T; Fiorillo A; Chiarini V; Genovese I; Ilari A; Colotti G
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32268494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorcin: a novel potential target in therapies of cancers.
    Zhou X; Wu X; Chen B
    Cancer Manag Res; 2019; 11():7327-7336. PubMed ID: 31496794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
    Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
    Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma.
    Lei X; Liang Y; Chen J; Xiao S; Lei J; Li J; Duanmu J; Jiang Q; Liu D; Tang C; Li T
    Sci Rep; 2017 Aug; 7(1):10049. PubMed ID: 28855589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.
    Genovese I; Fiorillo A; Ilari A; Masciarelli S; Fazi F; Colotti G
    Cell Death Dis; 2017 Jul; 8(7):e2950. PubMed ID: 28726784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What gastric cancer proteomic studies show about gastric carcinogenesis?
    Leal MF; Wisnieski F; de Oliveira Gigek C; do Santos LC; Calcagno DQ; Burbano RR; Smith MC
    Tumour Biol; 2016 Aug; 37(8):9991-10010. PubMed ID: 27126070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance.
    Danza K; Silvestris N; Simone G; Signorile M; Saragoni L; Brunetti O; Monti M; Mazzotta A; De Summa S; Mangia A; Tommasi S
    Cancer Biol Ther; 2016 Apr; 17(4):400-6. PubMed ID: 26793992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of Sorcin-mediated calcium-dependent signal transduction.
    Ilari A; Fiorillo A; Poser E; Lalioti VS; Sundell GN; Ivarsson Y; Genovese I; Colotti G
    Sci Rep; 2015 Nov; 5():16828. PubMed ID: 26577048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
    Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
    Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression.
    Huang YS; Xue Z; Zhang H
    Med Oncol; 2015 Feb; 32(2):470. PubMed ID: 25579168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.